AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in antibody drug discovery
Benz, J., Georges, G.To be published.
Experimental Data Snapshot
wwPDB Validation   3D Report Full Report
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
fAB heavy chain | A, C [auth H] | 227 | Homo sapiens | Mutation(s): 0  | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
fAB light chain | B, D [auth L] | 214 | Homo sapiens | Mutation(s): 0  | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 51.578 | α = 116.76 |
b = 67.301 | β = 89.17 |
c = 76.615 | γ = 105.07 |
Software Name | Purpose |
---|---|
BUSTER | refinement |
XDS | data reduction |
SADABS | data scaling |
PHASER | phasing |